Knowledge Center
Patent / Jun 29, 2017
Tetracycline topical formulations, preparation and uses thereof in treating an ocular condition
Source:
US 20170182071 A1 20170629
The invention relates to a topical suspension formulation that includes a tetracycline, a liq. medium and a polymeric gelling agent. The tetracycline may be in the form of its pharmaceutically acceptable salts, hydrates, or polymorphs and is in a suspended form within the formulation. The liq. medium is selected such that it does not dissolve or substantially minimally dissolves the tetracycline. The gelling agent is a polymeric hydrocarbon gelling agent. Preferably, the tetracycline has a particle size of less than or equal to about 20 μ.
Also in the Knowledge Center
Scientific Article
/ Jan 01, 2003
Vitro characterization of jet-milled and in-situ-micronized fluticasone-17-propionate
Read more
Scientific Article
/ Jan 01, 1991
Structure of [RhH2(PPh3)2(bipy)]Cl (bipy = 2,2'-bipyridyl) from multinuclear NMR studies
Read more
Scientific Article